admin

FDA Approves Vaccine While Doctors Urge Community to Get Vaccinated

On August 23, the U.S. Food and Drug Administration (FDA) approved the Pfizer-BioNTech COVID-19 Vaccine. The vaccine will now be marketed as Comirnaty for the prevention of COVID-19 disease in individuals 16 and older. It is also available under emergency use authorization (EUA), for individuals 12-15 years old. On the same day, a news conference …

FDA Approves Vaccine While Doctors Urge Community to Get Vaccinated Read More »

The First Florida Patient to Receive Biogen’s Aduhelm for Alzheimer’s Disease

Jeffrey Gelblum, MD, a board-certified neurologist with First Choice Neurology and Neuro2Go, the nation’s largest neurology practice, treated the first patient in Florida with Biogen’s Aduhelm (aducanumab), an infusion treatment for early-stage Alzheimer’s patients. Aduhelm decreases amyloid plaque in the brain, which is a marker for Alzheimer’s disease. Florida’s first Aduhelm patient is a middle-aged …

The First Florida Patient to Receive Biogen’s Aduhelm for Alzheimer’s Disease Read More »

COVID-19 Long-Haulers

According to the National Institutes of Health (NIH), at least one-third of people who had COVID-19 experience neurological complications. They are referred to as COVID-19 Long-Haulers. The most common COVID-19 Long-Haulers symptoms are fatigue, shortness of breath, trouble sleeping, headaches, and brain fog or difficulty thinking clearly. In a study conducted by NIH, participants experienced …

COVID-19 Long-Haulers Read More »

Translate »
Scroll to Top